1. Sun, Bingqing, Zhao, Hongwen. 2021. The bioinformatics analysis of RIOX2 gene in lung adenocarcinoma and squamous cell carcinoma. In PloS one, 16, e0259447. doi:10.1371/journal.pone.0259447. https://pubmed.ncbi.nlm.nih.gov/34855761/
2. He, Chenchen, Liu, Wang, Sun, Jiahao, Zhang, Da, Li, Benyi. 2023. Jumonji domain-containing protein RIOX2 is overexpressed and associated with worse survival outcomes in prostate cancers. In Frontiers in oncology, 13, 1087082. doi:10.3389/fonc.2023.1087082. https://pubmed.ncbi.nlm.nih.gov/36776320/
3. Zhang, Qian, Thakur, Chitra, Shi, Junwei, Stemmer, Paul, Chen, Fei. 2019. New discoveries of mdig in the epigenetic regulation of cancers. In Seminars in cancer biology, 57, 27-35. doi:10.1016/j.semcancer.2019.06.013. https://pubmed.ncbi.nlm.nih.gov/31276784/
4. Ferreira, Maria João, Pires-Luís, Ana Sílvia, Vieira-Coimbra, Márcia, Henrique, Rui, Jerónimo, Carmen. 2018. SETDB2 and RIOX2 are differentially expressed among renal cell tumor subtypes, associating with prognosis and metastization. In Epigenetics, 12, 1057-1064. doi:10.1080/15592294.2017.1385685. https://pubmed.ncbi.nlm.nih.gov/29099276/
5. Bi, Zhuoyue, Zhang, Qian, Fu, Yao, Thakur, Chitra, Chen, Fei. 2021. Cooperation between NRF2-mediated transcription and MDIG-dependent epigenetic modifications in arsenic-induced carcinogenesis and cancer stem cells. In Seminars in cancer biology, 76, 310-318. doi:10.1016/j.semcancer.2021.03.030. https://pubmed.ncbi.nlm.nih.gov/33823236/